Expand TNXP Menu
TNXP MENU

TNXP Stock Posts


TNXP stock declines -16.4% in premarket,

Premarket Decliner

TNXP Tonix Pharmaceuticals Holding Corp.20.17-6.50-24.4%

Premarket:16.86-3.31 (-16.4%)

Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year

ACCESS NewswireMon, 31-Mar 7:02 AM

TNXP stock declines -8.0% in after hours trading. See the latest news.

After Hours Decliner

TNXP Tonix Pharmaceuticals Holding Corp.20.53+4.25+26.1%

After Hours:18.89-1.64 (-8.0%)

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Globe NewswireTue, 18-Mar 4:30 PM

TNXP stock declines -11.1% in after hours trading. See the latest news.

After Hours Decliner

TNXP Tonix Pharmaceuticals Holding Corp.20.53+4.25+26.1%

After Hours:18.25-2.28 (-11.1%)

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Globe NewswireTue, 18-Mar 4:30 PM

TNXP stock declines -44.1% in premarket,

Premarket Decliner

TNXP Tonix Pharmaceuticals Holding Corp.2.13-0.08-3.6%

Premarket:1.19-0.94 (-44.1%)

Tonix Pharmaceuticals Announces Pricing of $4.0 Million Public Offering

Globe NewswireWed, 12-Jun 9:00 AM

TNXP stock declines -42.7% in premarket,

Premarket Decliner

TNXP Tonix Pharmaceuticals Holding Corp.1.78+0.06+3.5%

Premarket:1.02-0.76 (-42.7%)

Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering

Globe NewswireThu, 27-Jul 9:31 PM

TNXP stock increases 23.6% in premarket,

Premarket Gainer

TNXP Tonix Pharmaceuticals Holdings2.33-0.07-2.9%

Premarket:2.88+0.55 (+23.6%)

Tonix Pharmaceuticals Plans to Expand TNX-102 SL Phase 3 Program Beyond PTSD to Include Fibromyalgia

Globe NewswireThu, 4-Apr 7:30 AM

Market Data Delayed 15 Minutes